Are natural killer cells the key to treating Epstein-Barr virus–associated lymphoproliferative disorders?

Michael J. Robertson

Published in Volume 108, Issue 6

J Clin Invest. 2001; 108(6):801 doi:10.1172/JCI14003

Full text | PDF

Download citation in the following formats

• BibTex for BibDesk, Connotea, refbase
• RIS for Endnote, ProCite, Reference Manager
• Reference Manager (Windows)

If you experience problems using these citation formats, please send us feedback.